Universidad Peruana Cayetano Heredia

Assessing the use of biologic therapy for psoriasis in Latin America.

Mostrar el registro sencillo del ítem

dc.contributor.author Bravo Puccio, Francisco Gerardo
dc.coverage.spatial América Latina
dc.date.accessioned 2023-02-20T13:28:10Z
dc.date.available 2023-02-20T13:28:10Z
dc.date.issued 2023
dc.identifier.uri https://hdl.handle.net/20.500.12866/13138
dc.description.abstract The therapy of psoriasis has changed radically in the last 20 years. It has evolved from aiming at the functions of different cells involved in its pathogenesis (keratinocytes and cells of the immune system) to targeting highly specific immune mediators. Biologic therapy itself has evolved further, with new antibodies directed to interleukin (IL)-17 and IL-23 achieving higher disease clearance when compared with those directed towards other mediators such as tumour necrosis factor (TNF). Remarkably, the most recently introduced armamentaria include molecules with much better safety profiles, causing less overall immunosuppression and lower risk of tuberculosis reactivation, something relevant for South American countries with a high prevalence of tuberculosis... en_US
dc.language.iso eng
dc.publisher Wiley
dc.relation.ispartofseries British Journal of Dermatology
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Commentary en_US
dc.subject biologic therapy en_US
dc.subject psoriasis en_US
dc.subject Latin America en_US
dc.subject.mesh Comment
dc.subject.mesh Biological Therapy
dc.subject.mesh Psoriasis
dc.subject.mesh Latin America
dc.title Assessing the use of biologic therapy for psoriasis in Latin America. en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1093/bjd/ljad003
dc.relation.issn 1365-2133


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas